The accumulation of amyloid-β (Aβ) in the brain is a hallmark of Alzheimer’s disease, yet its distribution across brain regions is not uniform. Understanding why certain areas are more vulnerable than others before clinical symptoms appear remains a central question in neuroscience. This study investigates the regional patterns of Aβ, apolipoprotein E (apoE), synaptic markers, and other molecules involved in Aβ metabolism in non-demented individuals. Twelve brain regions—neocortical, limbic, and subcortical—were analyzed using a three-step sequential extraction method based on increasing insolubility. Levels of Aβ40, Aβ42, apoE, APP, APP-CTF, BACE1, presenilin-1, neprilysin, insulysin, LRP1, LDLR, synaptophysin, PSD95, GFAP, and lactate were quantified via ELISA or enzymatic assays.
Results revealed that the regional distribution of apoE showed a moderate-to-strong inverse correlation with Aβ levels, particularly insoluble Aβ40. In contrast, synaptic markers—especially PSD95—demonstrated a moderate-to-strong positive correlation with Aβ, particularly soluble Aβ40. These findings suggest that synapses may contribute to the initial accumulation of Aβ, while astrocyte-derived apoE may serve as a protective mechanism against such accumulation.Fluorescent brightener 71 Protocol Correlations between Aβ and LRP1, GFAP, or lactate were mild to moderate, indicating secondary roles in regional vulnerability. Notably, strong positive correlations were observed between apoE and GFAP or lactate, and between PSD95 and LRP1, supporting a functional link between synaptic integrity and clearance pathways.beta Amyloid 1-40 Antibody Epigenetics
Importantly, no significant regional correlations were found between Aβ and key Aβ-producing enzymes such as APP, APP-CTF, BACE1, or presenilin-1.PMID:34782242 Furthermore, no negative correlations emerged between Aβ and the major Aβ-degrading enzymes neprilysin or insulysin, suggesting these enzymes do not regulate regional Aβ levels under physiological conditions. These associations remained consistent regardless of the degree of Aβ accumulation or the presence of the APOE ε4 allele.
These findings support a model in which regional vulnerability to Aβ accumulation arises from a dynamic balance between two opposing processes: (1) synaptic activity promoting early Aβ deposition, and (2) astrocytic apoE limiting Aβ buildup. This dual mechanism may explain why neocortical and limbic regions—areas rich in synaptic connections—are preferentially affected early in the disease process. The data highlight the importance of both neuronal function and glial-mediated protection in determining where and when Aβ pathology begins, offering new insights into potential therapeutic targets aimed at modulating either synaptic activity or apoE function to delay or prevent Alzheimer’s disease onset.MedChemExpress (MCE) offers a wide range of high-quality research chemicals and biochemicals (novel life-science reagents, reference compounds and natural compounds) for scientific use. We have professionally experienced and friendly staff to meet your needs. We are a competent and trustworthy partner for your research and scientific projects.Related websites: https://www.medchemexpress.com